EC Number | Application | Comment | Organism |
---|---|---|---|
2.3.3.13 | medicine | potential target for drugs against microbial pathogens due to the absence of this enzyme in mammals | Mycobacterium tuberculosis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.3.3.13 | expressed as His-tag fusion protein in Escherichia coli BL21(DE3) | Mycobacterium tuberculosis |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.3.3.13 | sitting drop vapor diffusion method | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.3.13 | acetyl-CoA + alpha-ketoisovalerate + H2O | Mycobacterium tuberculosis | first step of leucine biosynthesis | alpha-isopropylmalate + CoA | - |
? | |
2.3.3.13 | acetyl-CoA + alpha-ketoisovalerate + H2O | Mycobacterium tuberculosis H37Rv | first step of leucine biosynthesis | alpha-isopropylmalate + CoA | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.3.13 | Mycobacterium tuberculosis | - |
- |
- |
2.3.3.13 | Mycobacterium tuberculosis H37Rv | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.3.3.13 | recombinant enzyme using His-tag | Mycobacterium tuberculosis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.3.13 | acetyl-CoA + alpha-ketoisovalerate + H2O | first step of leucine biosynthesis | Mycobacterium tuberculosis | alpha-isopropylmalate + CoA | - |
? | |
2.3.3.13 | acetyl-CoA + alpha-ketoisovalerate + H2O | reaction | Mycobacterium tuberculosis | alpha-isopropylmalate + CoA | - |
? | |
2.3.3.13 | acetyl-CoA + alpha-ketoisovalerate + H2O | first step of leucine biosynthesis | Mycobacterium tuberculosis H37Rv | alpha-isopropylmalate + CoA | - |
? | |
2.3.3.13 | acetyl-CoA + alpha-ketoisovalerate + H2O | reaction | Mycobacterium tuberculosis H37Rv | alpha-isopropylmalate + CoA | - |
? |